Clinical Trials · NCT02767596

Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

TerminatedPhase 4Lixisenatide (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Laniado Hospital
Enrollment
2
Start date
Jul 2016
Locations
1 site, Israel
Primary endpoint
Change in hemoglobin A1c
View Lixisenatide compound reference